| 1.21 -0.07 (-5.47%) | 02-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.63 | 1-year : | 1.82 |
| Resists | First : | 1.4 | Second : | 1.55 |
| Pivot price | 1.35 |
|||
| Supports | First : | 1.14 | Second : | 0.95 |
| MAs | MA(5) : | 1.31 |
MA(20) : | 1.36 |
| MA(100) : | 1.6 |
MA(250) : | 1.99 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 32.3 |
D(3) : | 43.8 |
| RSI | RSI(14): 36.9 |
|||
| 52-week | High : | 7.11 | Low : | 0.93 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IMCC ] has closed below the lower bollinger band by 12.2%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ IMCC ] is to continue within current trading range. It is unclear right now based on current values. 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.29 - 1.3 | 1.3 - 1.31 |
| Low: | 1.19 - 1.2 | 1.2 - 1.21 |
| Close: | 1.19 - 1.21 | 1.21 - 1.22 |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Fri, 30 Jan 2026
IMCC.CN IM Cannabis CNQ down 40% 30 Jan 2026: look for oversold bounce - Meyka
Mon, 26 Jan 2026
Medical cannabis firm raises US$2.17M loan to meet liquidity needs - Stock Titan
Mon, 26 Jan 2026
IM Cannabis Raises US$2.17 Million via Convertible Notes to Bolster Liquidity - TipRanks
Sun, 25 Jan 2026
IM Cannabis Corp. Secures $2.17 Million in Debt Financing - Intellectia AI
Mon, 05 Jan 2026
IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors - PR Newswire
Wed, 17 Dec 2025
IM Cannabis Corp. (NASDAQ:IMCC) Surges 40% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 5 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 44.6 (%) |
| Held by Institutions | 18.2 (%) |
| Shares Short | 61 (K) |
| Shares Short P.Month | 259 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.56 |
| Profit Margin | -9 % |
| Operating Margin | -7.8 % |
| Return on Assets (ttm) | -6.8 % |
| Return on Equity (ttm) | -119.8 % |
| Qtrly Rev. Growth | -0.3 % |
| Gross Profit (p.s.) | 2.33 |
| Sales Per Share | 9.97 |
| EBITDA (p.s.) | -0.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -4 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -2.43 |
| PEG Ratio | 0 |
| Price to Book value | 2.16 |
| Price to Sales | 0.12 |
| Price to Cash Flow | -1.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|